| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 1141 |
| 1 | CYCLOPHOSPHAMIDE | 990 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 990 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 990 |
| 4 | TACROLIMUS | 939 |
| 5 | DEXAMETHASONE | 925 |
| 6 | DEXAMETHASONE 1.5 MG | 925 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 832 |
| 8 | TACROLIMUS OINTMENT 0.1% | 831 |
| 9 | METHOTREXATE SODIUM | 825 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 58 | 0.0239 |
| 1 | ANIDULAFUNGIN | 37 | 0.0227 |
| 2 | CIDOFOVIR ANHYDROUS | 29 | 0.0201 |
| 3 | DEXRAZOXANE FOR INJECTION | 17 | 0.0180 |
| 4 | BUSULFAN | 275 | 0.0173 |
| 5 | I. V. FAT EMULSION | 11 | 0.0151 |
| 6 | OXACILLIN SODIUM | 17 | 0.0150 |
| 7 | NELARABINE | 14 | 0.0144 |
| 8 | DECITABINE | 62 | 0.0142 |
| 9 | GEMTUZUMAB OZOGAMICIN | 52 | 0.0142 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2986 |
| 1 | Alkylating Drug [EPC] | 1305 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 1247 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1102 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 890 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 789 |
| 6 | Platinum-based Drug [EPC] | 700 |
| 7 | Loop Diuretic [EPC] | 661 |
| 8 | Benzodiazepine [EPC] | 660 |
| 9 | Azole Antifungal [EPC] | 645 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CXC Chemokine Receptor 4 Antagonist [EPC] | 1 | 0.1250 |
| 1 | Interleukin-5 Antagonist [EPC] | 19 | 0.0276 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 58 | 0.0239 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 139 | 0.0237 |
| 4 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 5 | CD33-directed Immunoconjugate [EPC] | 52 | 0.0142 |
| 6 | Lipopeptide Antibacterial [EPC] | 121 | 0.0127 |
| 7 | Interferon gamma Blocker [EPC] | 3 | 0.0127 |
| 8 | Echinocandin Antifungal [EPC] | 103 | 0.0125 |
| 9 | Provitamin D2 Compound [EPC] | 311 | 0.0105 |